Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease.

Adam CR, Shrier E, Ding Y, Glazman S, Bodis-Wollner I.

J Neuroophthalmol. 2013 Jun;33(2):137-42. doi: 10.1097/WNO.0b013e31828c4e1a.

PMID:
23612240
2.

A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease.

Miri S, Glazman S, Mylin L, Bodis-Wollner I.

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S134-7. doi: 10.1016/j.parkreldis.2015.09.015. Epub 2015 Sep 5.

PMID:
26414119
3.

Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration.

Sari ES, Koc R, Yazici A, Sahin G, Ermis SS.

J Neuroophthalmol. 2015 Jun;35(2):117-21. doi: 10.1097/WNO.0000000000000203.

PMID:
25485861
4.

Morphologic and functional association of retinal layers beneath the epiretinal membrane with spectral-domain optical coherence tomography in eyes without photoreceptor abnormality.

Koo HC, Rhim WI, Lee EK.

Graefes Arch Clin Exp Ophthalmol. 2012 Apr;250(4):491-8. doi: 10.1007/s00417-011-1848-9. Epub 2011 Nov 16.

PMID:
22086759
5.

Remodeling of the fovea in Parkinson disease.

Spund B, Ding Y, Liu T, Selesnick I, Glazman S, Shrier EM, Bodis-Wollner I.

J Neural Transm (Vienna). 2013 May;120(5):745-53. doi: 10.1007/s00702-012-0909-5. Epub 2012 Dec 23.

PMID:
23263598
6.

Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography.

Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S.

Clin Ophthalmol. 2010 Dec 6;4:1427-32. doi: 10.2147/OPTH.S15136.

7.

Inner retinal layer thinning in Parkinson disease.

Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, Bodis-Wollner IG.

Arch Ophthalmol. 2009 Jun;127(6):737-41. doi: 10.1001/archophthalmol.2009.106. Erratum in: Arch Ophthalmol. 2009 Dec;127(12):1615.

PMID:
19506190
8.

Retinal nerve fiber layer thickness in Parkinson disease.

Kirbas S, Turkyilmaz K, Tufekci A, Durmus M.

J Neuroophthalmol. 2013 Mar;33(1):62-5. doi: 10.1097/WNO.0b013e3182701745.

PMID:
23100041
9.

Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease.

Garcia-Martin E, Satue M, Fuertes I, Otin S, Alarcia R, Herrero R, Bambo MP, Fernandez J, Pablo LE.

Ophthalmology. 2012 Oct;119(10):2161-7. doi: 10.1016/j.ophtha.2012.05.003. Epub 2012 Jun 28.

PMID:
22749083
10.

Development of a prediction formula of Parkinson disease severity by optical coherence tomography.

Jiménez B, Ascaso FJ, Cristóbal JA, López del Val J.

Mov Disord. 2014 Jan;29(1):68-74. doi: 10.1002/mds.25747. Epub 2013 Nov 14.

PMID:
24458320
11.

Three-dimensional imaging of macular inner structures in glaucoma by using spectral-domain optical coherence tomography.

Kotera Y, Hangai M, Hirose F, Mori S, Yoshimura N.

Invest Ophthalmol Vis Sci. 2011 Mar 14;52(3):1412-21. doi: 10.1167/iovs.10-5572.

PMID:
21087959
12.

The association of spectral-domain optical coherence tomography determined ganglion cell complex parameters and disease severity in Parkinson's disease.

Bayhan HA, Aslan Bayhan S, Tanık N, Gürdal C.

Curr Eye Res. 2014 Nov;39(11):1117-22. doi: 10.3109/02713683.2014.894080. Epub 2014 Mar 21.

PMID:
24655112
13.
14.

Interocular asymmetry of foveal thickness in Parkinson disease.

Shrier EM, Adam CR, Spund B, Glazman S, Bodis-Wollner I.

J Ophthalmol. 2012;2012:728457. doi: 10.1155/2012/728457. Epub 2012 Aug 1.

15.

Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease.

Altintaş O, Işeri P, Ozkan B, Cağlar Y.

Doc Ophthalmol. 2008 Mar;116(2):137-46. Epub 2007 Oct 26.

PMID:
17962989
16.

In Vivo Morphology of the Optic Nerve and Retina in Patients With Parkinson's Disease.

Pilat A, McLean RJ, Proudlock FA, Maconachie GD, Sheth V, Rajabally YA, Gottlob I.

Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4420-4427. doi: 10.1167/iovs.16-20020.

PMID:
27750285
17.

Reduction in retinal nerve fiber layer thickness in migraine patients.

Gipponi S, Scaroni N, Venturelli E, Forbice E, Rao R, Liberini P, Padovani A, Semeraro F.

Neurol Sci. 2013 Jun;34(6):841-5. doi: 10.1007/s10072-012-1103-0. Epub 2012 Apr 26.

PMID:
22535509
18.

Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations.

Ito Y, Nakamura M, Yamakoshi T, Lin J, Yatsuya H, Terasaki H.

Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4079-86.

PMID:
17724190
19.

Optical coherence tomography retinal thickness and volume measurements in X-linked retinoschisis.

Andreoli MT, Lim JI.

Am J Ophthalmol. 2014 Sep;158(3):567-73.e2. doi: 10.1016/j.ajo.2014.05.028. Epub 2014 May 28.

PMID:
24879947
20.

Thickness mapping of retinal layers by spectral-domain optical coherence tomography.

Loduca AL, Zhang C, Zelkha R, Shahidi M.

Am J Ophthalmol. 2010 Dec;150(6):849-55. doi: 10.1016/j.ajo.2010.06.034. Epub 2010 Oct 16.

Supplemental Content

Support Center